Fingerprint
Dive into the research topics of 'How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non- 18F-FDG PET radiopharmaceuticals'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non- 18F-FDG PET radiopharmaceuticals
Ka Kit Wong, Amanda M. Laird, Amir Moubayed, Sotirios Chondrogiannis, Maria Cristina Marzola, Laura Evangelista, Milton D. Gross, Domenico Rubello
Research output: Contribution to journal › Review article › peer-review
17
Scopus
citations